- US11707529utility2023Immunogenic Glycoprotein Conjugates0 cites
- US11708360utility2023N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides Useful as CCR6 Inhibitors0 cites
- US11702405utility2023Chemical Compounds0 cites
- US11702424utility2023Bicyclic-fused Heteroaryl or Aryl Compounds0 cites
- US11702474utility2023Antibodies Specific for CD47, PD-L1, and Uses Thereof0 cites
- US11691973utility20233,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-diones as MEK Inhibitors0 cites
- US11684616utility2023Azalactam Compounds as HPK1 Inhibitors0 cites
- US11680087utility2023Neisseria Meningitidis Compositions and Methods Thereof0 cites
- US11673890utility2023N1-pyrazolospiroketone Acetyl-coa Carboxylase Inhibitors0 cites
- US11673953utility2023DLL3 Targeting Chimeric Antigen Receptors and Binding Agents0 cites
- US11674240utility2023Universal Antibody Libraries0 cites
- US11661438utility2023Purification of Antibody Drug Conjugates Using a Sodium Phosphate Gradient0 cites
- US11661419utility2023Benzimidazole Derivative Compounds and Uses Thereof0 cites
- US11655252utility2023Aminopyrimidinyl Derivatives0 cites
- US11643412utility2023Melanocortin 4 Receptor Antagonists and Uses Thereof0 cites
- US11634410utility2023Substituted 3-azabicyclo[3.1.0]hexanes as Ketohexokinase Inhibitors0 cites
- US11634425utility2023Pharmaceutical Compounds0 cites
- US11634504utility2023Tissue Factor Pathway Inhibitor Antibodies and Uses Thereof0 cites
- US11629172utility2023Human Cytomegalovirus Gb Polypeptide0 cites
- US11613581utility2023Antibodies and Antibody-drug Conjugates Specific for CD123 and Uses Thereof0 cites